Mnemo Therapeutics is a biotechnology company. It develops cell therapies that create accessible cures for solid tumors and blood cancers. The company uses EnfiniT platform, a groundbreaking drug discovery engine, leverages a class of antigens with tumor specificity and a suite of technologies to improve T cell memory, persistence, and sensitivity.